https://www.selleckchem.com/products/abt-199.html
Genome-wide association studies (GWAS) have identified an association between polymorphisms in the FTO gene and obesity. The FTO rs9939609, an intronic variant, is considered a risk allele for developing diabesity in homozygous and heterozygous forms. This study aimed to investigate the molecular structure of the available inhibitors specific to the FTO mutations along with the rs9939609 variant. We identified the best-suited inhibitor molecules for each mutant type containing the rs9939609 risk allele. Missense mutations unique to obes